In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension
Yuan Yuan(Nanjing University of Chinese Medicine), Qinglei Gao(Tongji Hospital), Ning Zhou(Tongji Hospital), Siyuan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue Gao(Guangdong Provincial Center for Disease Control and Prevention), Dan Liu(Huazhong University of Science and Technology), Ruidi Yu(Tongji Hospital), Ya Wang(Tongji Hospital), Chunxia Zhao(The University of Adelaide), Huayi Li(Tongji Hospital), Shaoqing Zeng(Tongji Hospital), Xinxia Feng(Tongji Hospital), Sen Xu(Tongji Hospital)
Cited by 16
Related Papers
Biomarkers of aging
|Science China Life Sciences|2023|362
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
|Science China Life Sciences|2020|176
Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases
|Science China Life Sciences|2020|159